Author

Yi Su

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Integrated LC-MS/MS profiling, network pharmacology and experimental validation reveal inhibition of the IL-6/JAK2/STAT3 pathway by Shenqi Compound in comorbid chronic pancreatitis and type 2 diabetes mellitus.

SQC treatment is associated with the suppression of the IL-6/JAK2/STAT3 pathway, accompanied by reduced inflammation, decreased fibrosis, and improvements in both exocrine and endocrine functions in model mice, suggesting that the formula potentially acts as a holistic regulator.

Yi Su, Heng Yang, Xianrun Gong et al. · Journal of Ethnopharmacology · 0 citations

Review Open access Aug 2026

Antifibrotic mechanism of curcumin and its therapeutic potential in multi-organ diseases

This review outlines the mechanisms of action, safety, adverse effects, drug interactions, and the application of CUR-related nanocomposite products, thereby providing a foundation for in-depth research on its antifibrotic properties and clinical application.

Ting Luo, Jia Gao, Qing-Zhi Liang et al. · Frontiers in Pharmacology · 0 citations